Hsbc Holdings PLC Myriad Genetics Inc Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 30,214 shares of MYGN stock, worth $268,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,214
Previous 20,217 49.45%
Holding current value
$268,300
Previous $553,000 25.14%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$13.17 - $27.03 $131,660 - $270,218
9,997 Added 49.45%
30,214 $414,000
Q3 2024

Nov 14, 2024
SELL
$23.97 - $28.6 $191,184 - $228,113
-7,976 Reduced 28.29%
20,217 $553,000
Q2 2024

Aug 12, 2024
BUY
$17.98 - $25.47 $506,910 - $718,075
28,193 New
28,193 $689,000
Q4 2022

Feb 14, 2023
BUY
$14.51 - $20.99 $73,652 - $106,545
5,076 Added 39.54%
17,914 $259,000
Q3 2022

Nov 14, 2022
SELL
$18.21 - $27.88 $168,897 - $258,587
-9,275 Reduced 41.94%
12,838 $255,000
Q2 2022

Aug 11, 2022
SELL
$16.45 - $25.88 $54,679 - $86,025
-3,324 Reduced 13.07%
22,113 $408,000
Q1 2022

May 16, 2022
BUY
$22.67 - $28.01 $576,656 - $712,490
25,437 New
25,437 $648,000
Q3 2021

Nov 12, 2021
SELL
$29.97 - $36.66 $450,239 - $550,743
-15,023 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$25.39 - $32.61 $153,863 - $197,616
6,060 Added 67.61%
15,023 $459,000
Q1 2021

May 14, 2021
SELL
$19.92 - $31.6 $132,985 - $210,961
-6,676 Reduced 42.69%
8,963 $272,000
Q4 2020

Feb 12, 2021
BUY
$12.16 - $19.77 $190,170 - $309,183
15,639 New
15,639 $309,000
Q2 2020

Aug 14, 2020
SELL
$10.69 - $16.49 $117,322 - $180,977
-10,975 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$9.78 - $29.53 $29,965 - $90,479
-3,064 Reduced 21.82%
10,975 $157,000
Q4 2019

Feb 14, 2020
BUY
$20.93 - $35.1 $293,836 - $492,768
14,039 New
14,039 $387,000
Q2 2019

Aug 13, 2019
SELL
$22.67 - $35.0 $184,171 - $284,340
-8,124 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$26.93 - $34.7 $218,779 - $281,902
8,124 New
8,124 $270,000
Q3 2018

Nov 13, 2018
SELL
$37.57 - $50.34 $597,363 - $800,406
-15,900 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$27.75 - $40.17 $441,225 - $638,703
15,900 New
15,900 $593,000
Q4 2017

Feb 14, 2018
SELL
$28.45 - $37.14 $198,068 - $258,568
-6,962 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$24.01 - $36.2 $167,157 - $252,024
6,962
6,962 $252,000

Others Institutions Holding MYGN

# of Institutions
227
Shares Held
86M
Call Options Held
297K
Put Options Held
20.7K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $716M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email